grant

Plasminogen in glomerular disease progression

Organization ICAHN SCHOOL OF MEDICINE AT MOUNT SINAILocation NEW YORK, UNITED STATESPosted 1 Jul 2020Deadline 31 Aug 2030
NIHUS FederalResearch GrantFY2025Adhesion PlaquesAlbuminuriaAmilorideAssayBindingBioassayBiological AssayBiological MarkersBiopsyCell BodyCell surfaceCell-Matrix Adherens JunctionsCellsClinicalDetectionDevelopmentDiseaseDisease ProgressionDisorderDistalDropsyEC 3.4.21.7ENaCESKDESRDEdemaEnd stage renal failureEnd-Stage Kidney DiseaseEnd-Stage Renal DiseaseEnzyme PrecursorsEpithelial CellsFibrinolysinFocal AdhesionsFocal ContactsGlomerular diseaseGlu-PlasminGoalsHumanHydropsImmunoassayIn VitroInjuryKidneyKidney DiseasesKidney Urinary SystemLinear RegressionsLinkLiquid substanceLogistic RegressionsMeasuresMediatorMedicinal ChemistryMethodsModelingModern ManMolecularMolecular InteractionMorphologyNatureNephronsNephropathyOrganoidsOutcomePatientsPharmaceutic ChemistryPharmaceutical ChemistryPlasminPlasminogenProenzymesProfibrinolysinPropertyProtease FProtein FamilyProteinuriaRegenerative capacityRegulatory PathwayRenal DiseaseRenal Glomerular Diseases and SyndromesRenal functionRenal glomerular diseaseRenal glomerular disease or syndromeRenal glomerular disorderRenal glomerular syndromeResearchRiskRoleSerine EndopeptidasesSerine ProteaseSerine Protein HydrolasesSerine ProteinasesSurvival AnalysesSurvival AnalysisTestingTherapeuticU-PAU-Plasminogen ActivatorUrinary Plasminogen ActivatorUriniferous TubeUrokinaseUrokinase Plasminogen ActivatorUrokinase-Type Plasminogen ActivatorVisceral Epithelial CellWorkZymogensabsorptionbio-markersbiologic markerbiomarkerclinical relevanceclinically relevantcohortdecline in functiondecline in functional statusdevelopmentalefficacy testingepithelial Na+ channelepithelial sodium channelfluidfunctional declinefunctional status declineglomerular filtrationglomerular visceral epithelial cellin vivoinhibitorinjuriesinjury responsekidney disorderkidney functionliquidnebulettenebulinnew therapeutic approachnew therapeutic interventionnew therapeutic strategiesnew therapy approachesnew treatment approachnew treatment strategynovelnovel therapeutic approachnovel therapeutic interventionnovel therapeutic strategiesnovel therapy approachpodocyteprogression riskrational designregeneration abilityregeneration capacityrenalrenal disorderresponse to injurysocial roletherapeutic targeturinary
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Project Summary
Despite significant evidence identifying the podocyte as the key glomerular cell target for injury, validated

therapeutic targets are scarce and commercially available cell-specific therapy is lacking. Additionally, given the

heterogeneous nature of proteinuric kidney disease, biomarkers to identify patients at high versus low risk…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Plasminogen in glomerular disease progression — ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | UNITED STATES | Jul 2020 | Dev Procure